These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 4440585)
1. Short- and long-term approaches to the "on-off" phenomenon. Papavasiliou PS; Cotzias GC; Mena I Adv Neurol; 1974; 5():379-86. PubMed ID: 4440585 [No Abstract] [Full Text] [Related]
2. The "on-off" side effect of L-DOPA. Markham CH Adv Neurol; 1974; 5():387-96. PubMed ID: 4440586 [No Abstract] [Full Text] [Related]
3. The effects of combining carbidopa with levodopa for Parkinson's disease. Martin WE; Tolosa ES; Loewenson RB; Lee MC; Resch JA; Baker AB Geriatrics; 1975 Dec; 30(12):39-44. PubMed ID: 1104406 [No Abstract] [Full Text] [Related]
4. The "on-off" response to chronic L-DOPA treatment of Parkinsonism. Sweet RD; McDowell FH Adv Neurol; 1974; 5():331-8. PubMed ID: 4440581 [No Abstract] [Full Text] [Related]
5. The long-term effects of combining carbidopa with levodopa for Parkinson's disease. Lee MC; Lippert DM; Loewenson RB; Tolosa ES; Resch JA; Martin WE Trans Am Neurol Assoc; 1976; 101():262-4. PubMed ID: 829295 [No Abstract] [Full Text] [Related]
6. Treatment of Parkinson's disease with aporphines. Possible role of growth hormone. Cotzias GC; Papavasiliou PS; Tolosa ES; Mendez JS; Bell-Midura M N Engl J Med; 1976 Mar; 294(11):567-72. PubMed ID: 1107835 [TBL] [Abstract][Full Text] [Related]
7. Amantadine and a fixed combination of carbidopa and levodopa in parkinsonism: a preliminary report. Savery F Curr Ther Res Clin Exp; 1976 Mar; 19(3):337-8. PubMed ID: 817863 [No Abstract] [Full Text] [Related]
9. Unexpected findings with apomorphine and their possible consequences. Cotzias GC; Mena I; Papavasiliou PS; Mendez J Adv Neurol; 1974; 5():295-9. PubMed ID: 4440577 [No Abstract] [Full Text] [Related]
10. Treatment of parkinsonism with N-n-propyl norapomorphine and levodopa (with or without carbidopa). Papavasiliou PS; Cotzias GC; Rosal VL; Miller ST Arch Neurol; 1978 Dec; 35(12):787-91. PubMed ID: 363104 [TBL] [Abstract][Full Text] [Related]
11. [Carbiodopa-levodopa therapy (Sinemet) in the treatment of parkinsonian patients. Results of 4 years of treatment]. Martínez-Lage JM; Burguera JA; Deldago G; Zubieta JL Arch Neurobiol (Madr); 1978; 41(1):3-18. PubMed ID: 697513 [No Abstract] [Full Text] [Related]
12. Comparison of dopa decarboxylase inhibitor (carbidopa) combined with levodopa and levodopa alone in Parkinson's disease. Lieberman A; Goodgold A; Jonas S; Leibowitz M Neurology; 1975 Oct; 25(10):911-6. PubMed ID: 1101099 [TBL] [Abstract][Full Text] [Related]
13. Levodopa combined with MK 486 (L-alpha methyldopahydrazine)--a peripheral decarboxylase inhibitor in Parkinson's disease. Andrews CJ; Somerville B Med J Aust; 1974 Mar; 1(12):429-32. PubMed ID: 4598384 [No Abstract] [Full Text] [Related]
14. Treatment of "on-off effect" with a dopa decarboxylase inhibitor. Sweet RD; McDowell FH; Wasterlain CG; Stern PH Arch Neurol; 1975 Aug; 32(8):560-3. PubMed ID: 1156214 [TBL] [Abstract][Full Text] [Related]
15. [Effects and side effects to levodopa in parkinsonism- results of a collaborative study. (5) Combined therapy with a peripheral decarboxylase inhibitor]. Omoto T Rinsho Shinkeigaku; 1976 Dec; 16(12):879-80. PubMed ID: 1035531 [No Abstract] [Full Text] [Related]
16. Coupling of hypotensive and anit-Parkinson effects with two dopaminergic drugs. Düby SE; Dahl LK; Cotzias GC Trans Assoc Am Physicians; 1971; 84():289-96. PubMed ID: 5164305 [No Abstract] [Full Text] [Related]
17. L-alpha-methyldopa hydrazine (Carbidopa) combined with L-dopa in the treatment of Parkinson's disease. Glasgow GL; Henley JW; Willoughby EW Aust N Z J Med; 1974 Aug; 4(4):373-8. PubMed ID: 4278910 [No Abstract] [Full Text] [Related]
18. Levodopa, manganese, and degenerations of the brain. Cotzias GC Harvey Lect; 1974; 68():115-47. PubMed ID: 4452625 [No Abstract] [Full Text] [Related]
19. [Therapy of rigidity and hypokinesis in old age using Sinemet]. Drobný M; Adamkov J; Svaleková A; Fundárek J Cesk Neurol Neurochir; 1979 May; 42(3):195-204. PubMed ID: 455524 [No Abstract] [Full Text] [Related]
20. Madopar versus sinemet. A clinical study on their effectiveness. Korten JJ; Keyser A; Joosten EM; Gabreëls FJ Eur Neurol; 1975; 13(2):65-71. PubMed ID: 1095374 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]